Cargando…

p53 and angiogenesis in non-small-cell lung cancer: Reply to the letter from Giatromanolaki and Koukourakis

Detalles Bibliográficos
Autor principal:	Fontanini, G
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 1998
Materias:	Letters to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2149950/

Ejemplares similares

p53 and angiogenesis in non-small-cell lung cancer.
por: Giatromanolaki, A., et al.
Publicado: (1998)

Reply to the letter
por: Hirata, Naoyuki, et al.
Publicado: (2020)

Reply to Letter:
por: Dillinger, Jean-Guillaume, et al.
Publicado: (2020)

Reply to the letter
por: Hotta, Kunihisa
Publicado: (2020)

Reply to letter
por: Tam, Wilson, et al.
Publicado: (2021)

Reply to letter to editor
por: Sayanlar, Jennifer, et al.
Publicado: (2012)

Reply to the letter to editor
por: Sahasrabudhe, Parag
Publicado: (2015)

Reply to the Letter to the Editor
por: Garg, Megha
Publicado: (2021)

Reply to letter to the editor
por: McCarty, Sarah, et al.
Publicado: (2020)

Letter to Editor- Reply
por: Çatma, Mehmet Faruk, et al.
Publicado: (2020)

Reply to Letter to the Editor
por: Subramony, Rachna, et al.
Publicado: (2022)

Reply to the letter to the editor
por: Alio, Jorge L., et al.
Publicado: (2021)

Reply to Letter to Editor
por: Siow, Isabel, et al.
Publicado: (2021)

Reply to the Letter to the Editor
por: Alshahrani, Mohammed S
Publicado: (2022)

Reply to the letter to the editor
por: Hegde, Vishwajit, et al.
Publicado: (2023)

“p53 Polymorphism at Codon 72 and Breast Cancer” - Letter
por: Afzaljavan, Fahimeh, et al.
Publicado: (2017)

Referral Letter and Reply Form
por: Joob, Beuy, et al.
Publicado: (2014)

Link between p53 isoforms and angiogenesis: Current prospects
por: Bid, Hemant Kumar
Publicado: (2013)

Reply to: Comment on ‘Molecular evidence of viral DNA in non-small cell lung cancer and non-neoplastic lung’
por: Robinson, Lary A, et al.
Publicado: (2017)

Reply to the letter from Robertson to Blamey
Publicado: (1998)

Reply to letter by Drs Gillis and Hole
por: MacKie, R. M., et al.
Publicado: (1982)

Reply to the letter from Rettig and Lemon
por: Silva, Isabel dos Santos, et al.
Publicado: (1996)

Reply to the “Letter to the Editors” by Steven Buyske
por: Abu-Elneel, K., et al.
Publicado: (2009)

Reply to Letter from Dr. Tokudome
por: Sugimura, Takashi
Publicado: (1989)

Reply to the Letter to the Editor by Dr. Chirumbolo
por: Won, Dong Il
Publicado: (2016)

Reply to the Letter to the Editor by Sipila, Jussi
por: James, Lisa M, et al.
Publicado: (2022)

Letter to the Editor - Reply to Mr. Hytowitz
por: Gantz, Liat, et al.
Publicado: (2023)

Reply: The classification of p53 immunohistochemical staining results and patient outcome in ovarian cancer
por: de Graeff, P, et al.
Publicado: (2007)

Reply to Letter to the Editor
por: Keskinbora, Kadircan H., et al.
Publicado: (2020)

Reply to letter to the editor
por: Vailas, Michail, et al.
Publicado: (2021)

Reply: K-Ras: a prognostic factor for survival in non-small cell lung cancer
por: Mascaux, C
Publicado: (2006)

Reply to the letter from Poljak et al
por: Walboomers, JMM, et al.
Publicado: (1996)

Reply to the letter from Vermeuler et al
por: Hewitt, RE
Publicado: (1996)

Reply to Letter to the Editor by Yin et al.
por: Coleman, Brenda L., et al.
Publicado: (2021)

Reply Letter to “Cervical Facet Joint Degeneration”
por: Takeshima, Yasuhiro, et al.
Publicado: (2022)

Reply to Mrs. Stopes' Letter
Publicado: (1920)

Reply to letter to the editor: “Pathophysiology of Non-compaction Remains Enigmatic”
por: Kiss, Anna Reka, et al.
Publicado: (2022)

Reply to letter to the editor “antibody responses to second doses of COVID-19 vaccination in lung cancer patients: Comment”
por: Narita, Daisuke, et al.
Publicado: (2023)

Reply to letters on review ‘Evolving treatment strategies for myeloma’
por: Morgan, G J, et al.
Publicado: (2005)

Reply to the letter from Drs David and Sobrinho-Simões
por: Ikeda, Yoichi
Publicado: (1996)

Cannot write session to /tmp/vufind_sessions/sess_7n5d5me5kfhv6da4rooponbtk7